Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A note on ethnic sensitivity studies.

Michaela Glasbrenner¹, Gerd Rosenkranz

¹Biostatistics and Statistical Reporting, Novartis Pharma AG, Basel, Switzerland. michaela.glasbrenner@novartis.com

Journal of Biopharmaceutical Statistics

|January 31, 2006

Summary

This study introduces a new criterion for ethnic sensitivity studies in pharmacokinetics. It aids in designing studies, calculating sample sizes, and analyzing results for diverse populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis.

Pharmaceutical statistics·2018

Same author

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.

Scientific reports·2018

Same author

Applicability and added value of novel methods to improve drug development in rare diseases.

Orphanet journal of rare diseases·2018

Same author

Methods for the analysis of multiple endpoints in small populations: A review.

Journal of biopharmaceutical statistics·2018

Same author

Estimands-new statistical principle or the emperor's new clothes?

Pharmaceutical statistics·2016

Same author

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study.

Journal of neurodevelopmental disorders·2016

Area of Science:

Pharmacokinetics
Clinical Pharmacology
Drug Development

Background:

Ethnic variations can significantly impact drug pharmacokinetics.
Standardized methods are needed to assess ethnic sensitivity in drug studies.
Current approaches may lack a unified criterion for evaluating ethnic differences.

Purpose of the Study:

To propose a novel similarity criterion for ethnic sensitivity studies.
To demonstrate the application of this criterion across various dose-exposure models.
To provide guidance on sample size and power calculations for such studies.

Main Methods:

Development of a quantitative similarity criterion.
Application to different pharmacokinetic models (e.g., PBPK).
Methodology for sample size and power calculations based on the criterion.

Main Results:

The proposed criterion offers a standardized approach to assess ethnic sensitivity.
Demonstrated utility in planning and analyzing studies with diverse populations.
Facilitates robust statistical power for detecting relevant ethnic differences.

Conclusions:

The new criterion enhances the design and analysis of ethnic sensitivity studies.
It supports informed decision-making in drug development for global populations.
Provides a framework for reproducible and reliable ethnic pharmacokinetic assessments.

Related Experiment Videos